BARA·MED’s Hyperbaric Chambers Group Announces the Sale of One BARA-MED Select For Placement in Saudi Arabia

SOUTHAMPTON, PA, USA, April 10, 2013 – Environmental Tectonics Corporation (OTC Pink Sheets: BARA·MEDC) (“BARA·MED” or the “Company”) will install a state-of-the-art BARA-MED® “Select” hyperbaric chamber at King Saud General Hospital, the company announced Wednesday. King Saud General Hospital, Saudi Arabia, is a hospital under MOH (Ministry of Health) of Saudi Arabia.
BARA·MED International Sales and Marketing Manager Jamal Radford said, “We are pleased that King Saud General Hospital has chosen the BARA MED “Select” Monoplace Hyperbaric Chamber for their treatment solution.”
The BARA-MED “Select” is the first monoplace hyperbaric chamber on the market providing a unique gurney garage storage area for optimized space usage. It is suitable to accommodate patients up to 700 pounds. The BARA-MED “Select” comes standard with O.S.C.A.R.™ (Operating System for Control and Recordkeeping), an automatic control system which allows for programmable treatment profiles.
All BARA·MED chambers provide a patient-friendly pressurization alternative known as SMOOTH-RIDE™. This technology minimizes complications due to middle ear and sinus barotraumas without increasing compression time.

Forward-looking Statements
This news release contains forward-looking statements, which are based on management's expectations and are subject to uncertainties and changes in circumstances. Words and expressions reflecting something other than historical fact are intended to identify forward-looking statements, and these statements may include terminology such as "may", "will", "should", "expect", "plan", "anticipate", "believe", "estimate", "future", "predict", "potential", "intend", or "continue", and similar expressions. We base our forward-looking statements on our current expectations and projections about future events or future financial performance. Our forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about BARA·MED and its subsidiaries that may cause actual results to be materially different from any future results implied by these forward-looking statements. We caution you not to place undue reliance on these forward-looking statements.